Biological Assembly 1  

 3D View: Structure | Electron Density | Ligand Interaction

Standalone Viewers  
Protein Workshop | Ligand Explorer

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Hetero 2-mer - AB 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 23102.67 
• Atom Count: 1461 
• Residue Count: 199 
• Unique protein chains: 2

2XPX

Crystal structure of BHRF1:Bak BH3 complex

• DOI: 10.2210/pdb2XPX/pdb

• Classification: APOPTOSIS
• Organism(s): Epstein-Barr virus (strain B95-8), Homo sapiens
• Expression System: Escherichia coli BL21(DE3)


• Deposited: 2010-08-31 Released: 2011-01-26 
• Deposition Author(s): Kvansakul, M., Huang, D.C.S., Colman, P.M.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.05 Å
• R-Value Free: 0.217 
• R-Value Work: 0.184 

Literature

Structural Basis for Apoptosis Inhibition by Epstein-Barr Virus Bhrf1.

Kvansakul, M., Wei, A.H., Fletcher, J.I., Willis, S.N., Chen, L., Roberts, A.W., Huang, D.C.S., Colman, P.M.

(2010) Plos Pathog. 6: 1236

• PubMed: 21203485 
• DOI: 10.1371/journal.ppat.1001236
• Primary Citation of Related Structures:  
  2WH6, 2V6Q


• PubMed Abstract: 
  

Epstein-Barr virus (EBV) is associated with human malignancies, especially those affecting the B cell compartment such as Burkitt lymphoma. The virally encoded homolog of the mammalian pro-survival protein Bcl-2, BHRF1 contributes to viral infectivity and lymphomagenesis. In addition to the pro-apoptotic BH3-only protein Bim, its key target in lymphoid cells, BHRF1 also binds a selective sub-set of pro-apoptotic proteins (Bid, Puma, Bak) expressed by host cells. A consequence of BHRF1 expression is marked resistance to a range of cytotoxic agents and in particular, we show that its expression renders a mouse model of Burkitt lymphoma untreatable. As current small organic antagonists of Bcl-2 do not target BHRF1, the structures of it in complex with Bim or Bak shown here will be useful to guide efforts to target BHRF1 in EBV-associated malignancies, which are usually associated with poor clinical outcomes.

---

Organizational Affiliation: 

The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
APOPTOSIS REGULATOR BHRF1	A	173	Epstein-Barr virus (strain B95-8)	Mutation(s): 0
Find proteins for P03182 (Epstein-Barr virus (strain B95-8)) Go to UniProtKB:  P03182

Entity ID: 2
Molecule	Chains	Sequence Length	Organism	Details
BCL-2 HOMOLOGOUS ANTAGONIST/KILLER	B	26	Homo sapiens	Mutation(s): 0  Gene Names: BAK1 (BAK, BCL2L7, CDN1)
Find proteins for Q16611 (Homo sapiens) Go to Gene View: BAK1 Go to UniProtKB:  Q16611

Small Molecules

Ligands 2 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram & Interactions
EDO	A	1,2-ETHANEDIOL ETHYLENE GLYCOL C2 H6 O2 LYCAIKOWRPUZTN-UHFFFAOYSA-N
NO3	A	NITRATE ION N O3 NHNBFGGVMKEFGY-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.05 Å
• R-Value Free: 0.217 
• R-Value Work: 0.184 
• Space Group: P 3₂ 2 1

Unit Cell:

Length (Å)	Angle (°)
a = 62.387	α = 90.00
b = 62.387	β = 90.00
c = 93.729	γ = 120.00

Software Package:

Software Name	Purpose
PHASER	phasing
REFMAC	refinement

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2010-08-31 
• Released Date: 2011-01-26 
• Deposition Author(s): Kvansakul, M., Huang, D.C.S., Colman, P.M.

Revision History 

• Version 1.0: 2011-01-26
  Type: Initial release
• Version 1.1: 2011-12-28
  Type: Database references, Version format compliance